Four Engines. One Platform.

Resolves complete human genomes in under 130 seconds. Classifies 38,324 variants into three deterministic states: Positive, Ruled Out, and Uncertain. 100% ACMG SF v3.2 secondary findings coverage with quality thresholds of GQ≥30 and DP≥20.

Fuses genomic variants with laboratory biomarkers in 75 seconds. Cross-references 1,769,149 clinical rules to output pharmacogenomic recommendations with star alleles and PMID citations. FHIR-native export to Epic and Cerner.

A high-performance genomic discovery engine that identifies deterministic convergence in biological systems, delivering 1,000-generation benchmarks in 130 seconds and scaling to 5,000-generation runs for deeper analysis. The same constrained interaction patterns emerge across independent runs, exposing constraint rather than randomness. Built on in-memory execution across 23.7M+ anchored molecular reference assets, with k-anonymity enforced at the SQL layer. The Study Dossier production layer converts that deterministic evidence into research-grade artifacts under closed-world AI constraints, with cryptographic provenance and validator-gated export.

An autonomous discovery engine that compounds infrastructure output into testable hypotheses. Genome resolutions, multi-omic fusions, and evolutionary signals feed a closed-world reasoning loop that surfaces druggable targets, mechanism candidates, and repositioning leads with cryptographic provenance. Full architecture reserved for partners.